National Asset Management, Inc. Moderna, Inc. Transaction History

National Asset Management, Inc.

$3.51 Billion
Q3 2024

A detailed history of National Asset Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 5,229 shares of MRNA stock, worth $219,618. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,229

Previous 6,117 14.52%

Holding current value

$219,618

Previous $726,000 51.93%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 13, 2024	SELL	$63.64 - $125.14 $56,512 - $111,124	-888 Reduced 14.52%	5,229 $349,000
Q2 2024 Aug 19, 2024	SELL	$101.21 - $166.61 $379,942 - $625,453	-3,754 Reduced 38.03%	6,117 $726,000
Q1 2024 May 16, 2024	BUY	$85.37 - $115.44 $132,238 - $178,816	1,549 Added 18.61%	9,871 $1.05 Million
Q4 2023 Mar 15, 2024	SELL	$69.51 - $104.43 $107,670 - $161,762	-1,549 Reduced 15.69%	8,322 $827,000
Q3 2023 Dec 01, 2023	BUY	$96.41 - $126.61 $155,798 - $204,601	1,616 Added 19.58%	9,871 $1.02 Million
Q2 2023 Jul 27, 2023	BUY	$118.5 - $160.53 $80,106 - $108,518	676 Added 8.92%	8,255 $1 Million
Q1 2023 May 17, 2023	SELL	$135.66 - $197.02 $339,556 - $493,141	-2,503 Reduced 24.83%	7,579 $1.16 Million
Q4 2022 Feb 21, 2023	BUY	$118.38 - $210.04 $56,585 - $100,399	478 Added 4.98%	10,082 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $315,837 - $519,431	2,675 Added 38.61%	9,604 $1.14 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $39,941 - $60,217	341 Added 5.18%	6,929 $990,000
Q1 2022 May 02, 2022	SELL	$126.46 - $235.05 $333,348 - $619,591	-2,636 Reduced 28.58%	6,588 $1.14 Million
Q4 2021 Jan 28, 2022	SELL	$225.82 - $368.51 $380,055 - $620,202	-1,683 Reduced 15.43%	9,224 $2.34 Million
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $2.06 Million - $4.5 Million	-9,293 Reduced 46.0%	10,907 $4.11 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $1.14 Million - $2.05 Million	-8,739 Reduced 30.2%	20,200 $4.69 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $350,031 - $596,251	3,206 Added 12.46%	28,939 $3.78 Million
Q4 2020 Feb 04, 2021	BUY	$65.74 - $169.86 $713,279 - $1.84 Million	10,850 Added 72.9%	25,733 $2.69 Million
Q3 2020 Nov 09, 2020	BUY	$54.34 - $94.85 $217,251 - $379,210	3,998 Added 36.73%	14,883 $1.05 Million
Q2 2020 Jul 31, 2020	BUY	$29.67 - $80.0 $322,957 - $870,800	10,885 New	10,885 $699,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Moderna, Inc. Transaction History